CHU Dijon - Hôpital François Mitterrand — Dijon

Public research footprint of CHU Dijon - Hôpital François Mitterrand, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Acute Myocardial Infarction · Type 1 Diabetes · Acute Kidney Injury Due to Sepsis · Giant Cell Arteritis (GCA)

Recently updated registry entries

NCT07317102 — Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B) (Recruiting)
NCT07060274 — Halo Sign Vanishing Time After Steroids Outbreak in GCA Patients (Recruiting)
NCT07202897 — LA-HCM Study : Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHU Dijon - Hôpital François Mitterrand?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.